2017
DOI: 10.1002/mabi.201700185
|View full text |Cite
|
Sign up to set email alerts
|

Design of a Novel Two‐Component Hybrid Dermal Scaffold for the Treatment of Pressure Sores

Abstract: The aim of this study is to design a novel two-component hybrid scaffold using the fibrin/alginate porous hydrogel Smart Matrix combined to a backing layer of plasma polymerized polydimethylsiloxane (Sil) membrane to make the fibrin-based dermal scaffold more robust for the treatment of the clinically challenging pressure sores. A design criteria are established, according to which the Sil membranes are punched to avoid collection of fluid underneath. Manual peel test shows that native silicone does not attach… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
18
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
4
3

Relationship

2
5

Authors

Journals

citations
Cited by 17 publications
(19 citation statements)
references
References 52 publications
0
18
0
Order By: Relevance
“…Our laboratory has developed a porous, cross-linked fibrin/alginate scaffold for the treatment of acute full thickness skin wounds and is currently in clinical trials. 11 14 The scaffold has exhibited promising advantages in terms of retarding degradation and improving cell ingress, thus enhancing tissue regeneration and establishment of a blood supply. 11 , 12 Since angiogenesis is key for successful bone regeneration, 2 , 3 we hypothesized that our pro-angiogenic fibrin/alginate scaffold could be used for bone tissue engineering applications by adding an osteogenic component to the scaffold, such as a calcium-phosphate (CaP).…”
Section: Introductionmentioning
confidence: 99%
“…Our laboratory has developed a porous, cross-linked fibrin/alginate scaffold for the treatment of acute full thickness skin wounds and is currently in clinical trials. 11 14 The scaffold has exhibited promising advantages in terms of retarding degradation and improving cell ingress, thus enhancing tissue regeneration and establishment of a blood supply. 11 , 12 Since angiogenesis is key for successful bone regeneration, 2 , 3 we hypothesized that our pro-angiogenic fibrin/alginate scaffold could be used for bone tissue engineering applications by adding an osteogenic component to the scaffold, such as a calcium-phosphate (CaP).…”
Section: Introductionmentioning
confidence: 99%
“…Two different dermal substitutes were used: the commercially available and clinically well-established Integra and Smart Matrix which is manufactured in our laboratory and is currently undergoing clinical testing. 12 14 Variables and levels investigated were as follows: (1) cell passage number (5 or 10); (2) cell seeding density (1.25 × 10 5 , 2.5 × 10 5 , or 5 × 10 5 cells in 200 µL), (3) scaffold disc to well plate surface area ratio (1:1 or 1:6); (4) attachment incubation time (3 or 24 h). The rationale for the chosen cell seeding densities was based on our previous and extensive experience with these materials: 12 14 the maximum number of cells that can be seeded per 6-mm-diameter disc of material is 5 × 10 5 .…”
Section: Methodsmentioning
confidence: 99%
“…Similarly, we know from experience that the other chosen variables affect the cell seeding efficiency on these scaffolds. 12 14 A full factorial experimental design was used (2 × 2 × 2 × 3). A matrix of variables and levels was created ( Figure 1 ) and for each individual set of experimental conditions, three replicates were performed (n = 3).…”
Section: Methodsmentioning
confidence: 99%
See 2 more Smart Citations